Circulating immune complexes in children suffering from rheumatic fever and juvenile rheumatoid arthritis

Insights

Circulating immune complexes were found in most children with rheumatic fever and juvenile rheumatoid arthritis. Their levels decreased during treatment, indicating therapeutic effectiveness in reducing these inflammatory markers.

Area of Science:

  • Pediatric Rheumatology
  • Immunology

Background:

  • Rheumatic fever (RF) and juvenile rheumatoid arthritis (JRA) are inflammatory conditions in children.
  • Immune complexes are implicated in the pathogenesis of autoimmune and inflammatory diseases.

Purpose of the Study:

  • To investigate the presence and levels of circulating immune complexes in children with RF and JRA.
  • To assess changes in immune complex concentrations during treatment for these conditions.

Main Methods:

  • Study included 20 children with RF, 15 with JRA, and 15 healthy controls.
  • Circulating immune complexes were detected and quantified.
  • Protein concentration was measured using the PEG precipitation method at weeks 3 and 6 of treatment.

Main Results:

  • Immune complexes were detected in 50% of children with acute RF and 80% of children with JRA.
  • A decrease in protein concentration, indicative of reduced immune complexes, was observed by the third and sixth weeks of treatment.

Conclusions:

  • Circulating immune complexes are frequently present in pediatric rheumatic diseases like RF and JRA.
  • Treatment regimens appear effective in reducing immune complex levels in these conditions.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...